PTX 2.44% 4.2¢ prescient therapeutics limited

Ann: PTX-200 AML Trial Progresses to Higher Dose, page-32

  1. 1,656 Posts.
    lightbulb Created with Sketch. 198
    Again thanks for your clarity AMS.
    If it is the case, as you pointed out, that none of the 3 in this cohort showed an clinical response then the continued escalation of dose makes sense. Of course, this questions the amendment of the protocol itself.
    Have a great weekend, thanks for the clarity.
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.